Antiproliferative and Apoptotic Effects of Iron Chelators on Human Cervical Carcinoma Cells
- 1 April 2002
- journal article
- Published by Elsevier in Gynecologic Oncology
- Vol. 85 (1), 95-102
- https://doi.org/10.1006/gyno.2001.6570
Abstract
No abstract availableThis publication has 27 references indexed in Scilit:
- Iron Chelators Inhibit the Growth and Induce the Apoptosis of Kaposi's Sarcoma Cells and of their Putative Endothelial PrecursorsJournal of Investigative Dermatology, 2000
- Prevention of cervix cancerCritical Reviews in Oncology/Hematology, 2000
- Inhibition of Human Immunodeficiency Virus Type 1 Replication in Human Mononuclear Blood Cells by the Iron Chelators Deferoxamine, Deferiprone, and BleomycinThe Journal of Infectious Diseases, 2000
- HIGH DOSE RATE BRACHYTHERAPY IN THE TREATMENT OF CERVICAL CARCINOMAHematology/Oncology Clinics of North America, 1999
- Iron withholding: A defense against viral infectionsBioMetals, 1996
- Iron deprivation‐induced apoptosis in HL‐60 cellsFEBS Letters, 1994
- Recent Progress in Defining the Epidemiology of Human Papillomavirus Infection and Cervical NeoplasiaJNCI Journal of the National Cancer Institute, 1992
- Iron in CancerPathobiology, 1992
- Human papillomaviruses in the pathogenesis of anogenital cancerVirology, 1991
- Effect of Iron and Desferoxamine on Cell Growth And In Vitro Ferritin Synthesis in Human Hepatoma Cell LinesHepatology, 1990